Bromazepam is a benzodiazepine anxiolytic used for the short-term management of anxiety disorders through GABA-A receptor potentiation. Simson Pharma's Bromazepam reference standard and impurities support compendial and controlled-substance-aligned testing for this widely used anxiolytic.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bromazepam Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.